Checck Me DOA 6 Panel Urine Drug Test Kit - Combo Pack of 2 Cassettes

About this product

Most comprehensive and trusted 6 Panel tetrahydrocannabinol, amphetamine, barbiturates, benzodiazepine, barbiturates, cocaine and opiates in human urine.Tests for 6 popular Drugs: Marijuana (THC), Opiate (OPI), Cocaine (COC), Amphetamine (AMP), Barbiturates(BAR), Benzodiazepines (BZO).Cutoff level: THC - 50 ng/mL; COC - 300 ng/mL; OPI - 300 ng/mL; BZO - 300 ng/mL; AMP - 1000 ng/mL; BAR - 300 ng/mL1) Bring the kit components of INSIGHT DOA Panel 6.1 device to room temperaturebefore testing. (2) Open a foil pouch by tearing along the “notch”. (3) Remove the testingdevice and the sample applicator and the desiccant pouch. (4) Once opened, the device must be usedimmediately. (5) Place the testing device on a flathorizontal surface. (6) Use the provided sample applicator to pick up the urine sample andfill the applicator exactly upto the '0.5' mark. (7) Dispense all the urine samples picked upby applicator to the sample well (S) of the device drop by drop. Avoid trapping air bubbles inthe sample well, while dispensing the sample. Alternatively, carefully dispense 500 μl urinespecimen to the sample well (S) using a micropipette. (8) Start the stop watch and read theresults at the end of 5 minutes in each test window for the specific drug parameter.Negative Result:Two pink coloured bands appear at the control region (C) and test region (T). This indicates absence of the specificdrug in the specimen.Positive Result:One pink coloured band appears at the control region (C). This indicates that the specimen contains detectableamount of the specific drug.Invalid Result:The test result is invalid if no band appears either at the control region (C) or test region (T). In such cases, verify thetest procedure and repeat the test with a INSIGHT DOA Panel 6.1 device.Important: Do not interpret the results beyond 8 minutes. A very faint line on the test region indicates that the drug in the specimen is near thecut-off level for the test. These specimen should be re-tested or confirmed with a more specific method before a positive determination ismade. • CHECCK ME • 2 • Urine Drug Test • Most comprehensive and trusted 6 Panel tetrahydrocannabinol, amphetamine, barbiturates, benzodiazepine, barbiturates, cocaine and opiates in human urine. Tests for 6 popular Drugs: Marijuana (THC), Opiate (OPI), Cocaine (COC), Amphetamine (AMP), Barbiturates(BAR), Benzodiazepines (BZO). Cutoff level: THC - 50 ng/mL; COC - 300 ng/mL; OPI - 300 ng/mL; BZO - 300 ng/mL; AMP - 1000 ng/mL; BAR - 300 ng/mL 1) Bring the kit components of INSIGHT DOA Panel 6.1 device to room temperature before testing. (2) Open a foil pouch by tearing along the “notch”. (3) Remove the testing device and the sample applicator and the desiccant pouch. (4) Once opened, the device must be used immediately. (5) Place the testing device on a flat horizontal surface. (6) Use the provided sample applicator to pick up the urine sample and fill the applicator exactly upto the '0.5' mark. (7) Dispense all the urine samples picked up by applicator to the sample well (S) of the device drop by drop. Avoid trapping air bubbles in the sample well, while dispensing the sample. Alternatively, carefully dispense 500 μl urine specimen to the sample well (S) using a micropipette. (8) Start the stop watch and read the results at the end of 5 minutes in each test window for the specific drug parameter. Negative Result: Two pink coloured bands appear at the control region (C) and test region (T). This indicates absence of the specific drug in the specimen. Positive Result: One pink coloured band appears at the control region (C). This indicates that the specimen contains detectable amount of the specific drug. Invalid Result: The test result is invalid if no band appears either at the control region (C) or test region (T). In such cases, verify the test procedure and repeat the test with a INSIGHT DOA Panel 6.1 device. Important: Do not interpret the results beyond 8 minutes. A very faint line on the test region indicates that the drug in the specimen is near the cut-off level for the test. These specimen should be re-tested or confirmed with a more specific method before a positive determination is made.